Expert Insights

Pharmaceutical Industry News Roundup: May 2020

Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from May, including: FDA Coronavirus (COVID-19) Update, 2019 Avoca State of the Industry Report, PHUSE clinical trial transparency project, and more.

With Safety, Urgency, and Innovation: How an Award-Winning CRO Operates During COVID-19

By Staff Writer, April 28, 2020
The COVID-19 pandemic has impacted the way many pharmaceutical, biotech, and CRO companies are working, rewarding flexibility and agile resourcing and operating models. In this expert insights blog, we sit down (virtually) with Kelly J. Hill, Executive Director, Global Business Operations and Strategy and Michelle Gayari, Executive Director, Global Operations to learn how MMS operates with safety, urgency, and innovation during this pandemic.

Whitepaper: Six Changes that Pharmaceutical Companies Should Consider in Response to COVID-19

Experts at MMS have reviewed COVID-19 guidance documents and taken into account the current state of clinical research globally to ensure our services align with these new challenges, whether those sponsors be virtual or large firms with treatments for common illnesses or rare conditions. What has been identified in this whitepaper are key areas of change faced by the industry.

Unprecedented does not have to mean unprepared: Business Continuity Planning

by Jessica Alamdari, April 3, 2020
During these unprecedented times, many businesses are struggling to continue business as usual while the world is rapidly changing around them; however, certain businesses continue to thrive. Throughout this COVID-19 pandemic, companies like MMS, among other leaders in the pharmaceutical industry, are not only carrying out typical day-to-day business operations, but they are well-positioned to offer additional support to companies unable to adapt.

The New Roaring 20s: 12 Experts Provide Pharmaceutical Insights for the Decade Ahead

by Aaron Robert, February 7, 2020
The pharmaceutical industry—and healthcare in general—are in constant stages of innovation. According to the International Federation of Pharmaceutical Manufacturers & Associations, the number of new chemical or biological entities launched on the world market stood at 226 from the years 2011 to 2015, a 35 percent increase from the decade prior.


6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us


Learn more about working with MMS

14 + 14 =

© MMS Holdings Inc. All rights reserved. Privacy Policy